date:Sep 10, 2013
s and GSK's Coleford manufacturing site, which is located in the Forest of Dean in Britain.
The vast majority of employees at the site and those working on Lucozade and Ribena in commercial and RD functions will transfer to SBF under the provisions of English employment law, said GSK.
In Nigeria, GSK will continue to manufacture and distribute Lucozade and Ribena under the license from SBF.
Annual sales of the two brands were approximately 500 million pounds in 2012, according to GSK.